![](/img/cover-not-exists.png)
Patient and caregiver outcomes after 6 ± 1.5-months of rivastigmine therapy for mild-to-moderate Alzheimer's disease:the Belgian FExT study
Mets, Tony, Vandewoude, Maurits, Jacquy, Jean, Deblander, Anne, MacDonald, Karen, Sloesen, Anne, Abraham, IvoVolume:
23
Language:
english
Journal:
Current Medical Research and Opinion
DOI:
10.1185/030079907x226375
Date:
October, 2007
File:
PDF, 616 KB
english, 2007